✦ LIBER ✦
In T2D patients with baseline A1c <8.0%, liraglutide achieves A1c targets more often than sitagliptin or exenatide
✍ Scribed by King, A.; Montanya, E.; Pratley, R.; Blonde, L.; Svendsen, C.; Donsmark, M.; Sesti, G.
- Book ID
- 122562086
- Publisher
- Elsevier
- Year
- 2013
- Tongue
- English
- Weight
- 53 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1751-9918
No coin nor oath required. For personal study only.